{"data":{"id":"us-mt/37-27-302","jurisdiction":"us-mt","citation":"37-27-302","heading":"Administration of prescription drugs -- when prohibited -- when allowed -- protocols -- rulemaking.","body":"(1) Except as provided in subsections (2) and (3), a licensed direct-entry midwife may not dispense or administer prescription drugs.\n(2) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology and intravenous therapy approved by the board and has obtained a license endorsement from the board may, during the practice of midwifery, directly obtain and administer the following:\n(a) oxygen;\n(b) postpartum antihemorrhagic agents, including:\n(i) pitocin (intramuscular);\n(ii) methylergonovine;\n(iii) misoprostol;\n(iv) tranexamic acid; and\n(v) other postpartum antihemorrhagic drugs allowed by board rule;\n(c) injectable local anesthetics for the repair of up to second-degree lacerations;\n(d) antibiotics for group b streptococcus prophylaxis consistent with guidelines of the United States centers for disease control and prevention;\n(e) epinephrine administered for anaphylactic shock;\n(f) intravenous fluids for fluid replacement and administration of approved medications;\n(g) rho(d) immune globulin to prevent maternal immune sensitization to certain fetal blood types;\n(h) newborn vitamin K or phytonadione (oral or intramuscular preparations);\n(i) in accordance with administrative rules adopted by the department of public health and human services, prophylactic eye agents to newborn infants; and\n(j) other medications as prescribed by a medical practitioner or naturopathic physician, including the use of devices as defined in 37-2-101.\n(3) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology pursuant to subsection (2) may, during the practice of midwifery:\n(a) directly obtain terbutaline; and\n(b) administer terbutaline to a patient when given a direct order to do so from a licensed physician.\n(4) A licensed direct-entry midwife who administers drugs under this section must establish written protocol, including but not limited to:\n(a) procurement of prescription drugs, which must be procured from a wholesale drug distributor or pharmacy supplier licensed by the board of pharmacy provided for in 2-15-1733;\n(b) storage, inventory control, and disposal of prescription drugs; and\n(c) use and care of prescription drugs.\n(5) The board may adopt rules to implement this section.","path":["TITLE 37. PROFESSIONS AND OCCUPATIONS","CHAPTER 27. DIRECT-ENTRY MIDWIFERY","Part 3. Regulation of Practice"],"source_url":"https://mca.legmt.gov/bills/mca/title_0370/chapter_0270/part_0030/section_0020/0370-0270-0030-0020.html","current_through":"Montana Code Annotated 2025","vintage":"","retrieved_at":"2026-09-14T04:54:00Z","sha256":"d5a7407502d89570a236aa1ea17cbf10413e90724b6a82b4e8b6e01558f4a2a3","source_id":"us-mt","stale":false,"prev":"us-mt/37-27-301","next":"us-mt/37-27-303"},"notice":"GroundRules: Original legal text. Not legal advice."}